A DNA Hypomethylation Signature Predicts Antitumor Activity of LSD1 Inhibitors in SCLCHelai P. Mohammad, Ryan G. Kruger, Yan Degenhardt et al.|Cancer Cell|2015Cited by 518
Discovery of GSK2126458, a Highly Potent Inhibitor of PI3K and the Mammalian Target of RapamycinSteven D. Knight, Dashyant Dhanak, Nicholas D. Adams et al.|ACS Medicinal Chemistry Letters|2010Cited by 374
Effects of oncogenic p110α subunit mutations on the lipid kinase activity of phosphoinositide 3-kinaseJeffrey D. Carson, Lusong Luo, Glenn Van Aller et al.|Biochemical Journal|2007Cited by 119
Inhibition Of LSD1 As a Therapeutic Strategy For The Treatment Of Acute Myeloid LeukemiaRyan G. Kruger, Peter J. Tummino, Helai P. Mohammad et al.|Blood|2013Cited by 30
Conformation-Dependent Ligand Regulation of ATP Hydrolysis by Human KSP: Activation of Basal Hydrolysis and Inhibition of Microtubule-Stimulated Hydrolysis by a Single, Small Molecule ModulatorLusong Luo, Robert A. Copeland, Jeffrey D. Carson et al.|Journal of the American Chemical Society|2008Cited by 16